The Novel SSTR3 Full Agonist ITF2984 Shows Antitumor Properties against Pancreatic Neuroendocrine Tumors.
Saved in:
| Title: | The Novel SSTR3 Full Agonist ITF2984 Shows Antitumor Properties against Pancreatic Neuroendocrine Tumors. |
|---|---|
| Authors: | Bistika M; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Marangelo A; Institute for Diabetes and Cancer, Helmholtz Zentrum München, Neuherberg, Germany.; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany., Ascione F; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Valentini N; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Fedeli F; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., Schrader J; Department of Medicine, Klinikum Nordfriesland, Husum, Germany., Modena D; Preclinical R&D, Italfarmaco Group, Milan, Italy., Steinkühler C; Preclinical R&D, Italfarmaco Group, Milan, Italy., Pellegata NS; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy.; Institute for Diabetes and Cancer, Helmholtz Zentrum München, Neuherberg, Germany.; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany. |
| Source: | Neuroendocrinology [Neuroendocrinology] 2025; Vol. 115 (5), pp. 446-459. Date of Electronic Publication: 2024 Dec 28. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Karger Country of Publication: Switzerland NLM ID: 0035665 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0194 (Electronic) Linking ISSN: 00283835 NLM ISO Abbreviation: Neuroendocrinology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39733775 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The Novel SSTR3 Full Agonist ITF2984 Shows Antitumor Properties against Pancreatic Neuroendocrine Tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bistika+M%22">Bistika M</searchLink>; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Marangelo+A%22">Marangelo A</searchLink>; Institute for Diabetes and Cancer, Helmholtz Zentrum München, Neuherberg, Germany.; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Ascione+F%22">Ascione F</searchLink>; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Valentini+N%22">Valentini N</searchLink>; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Fedeli+F%22">Fedeli F</searchLink>; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Schrader+J%22">Schrader J</searchLink>; Department of Medicine, Klinikum Nordfriesland, Husum, Germany.<br /><searchLink fieldCode="AU" term="%22Modena+D%22">Modena D</searchLink>; Preclinical R&D, Italfarmaco Group, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Steinkühler+C%22">Steinkühler C</searchLink>; Preclinical R&D, Italfarmaco Group, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Pellegata+NS%22">Pellegata NS</searchLink>; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy.; Institute for Diabetes and Cancer, Helmholtz Zentrum München, Neuherberg, Germany.; Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220035665%22">Neuroendocrinology</searchLink> [Neuroendocrinology] 2025; Vol. 115 (5), pp. 446-459. <i>Date of Electronic Publication: </i>2024 Dec 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Karger%22">Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>0035665 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1423-0194 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200283835%22">00283835 </searchLink><i>NLM ISO Abbreviation: </i>Neuroendocrinology <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39733775 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1159/000543136 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 446 Titles: – TitleFull: The Novel SSTR3 Full Agonist ITF2984 Shows Antitumor Properties against Pancreatic Neuroendocrine Tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bistika M – PersonEntity: Name: NameFull: Marangelo A – PersonEntity: Name: NameFull: Ascione F – PersonEntity: Name: NameFull: Valentini N – PersonEntity: Name: NameFull: Fedeli F – PersonEntity: Name: NameFull: Schrader J – PersonEntity: Name: NameFull: Modena D – PersonEntity: Name: NameFull: Steinkühler C – PersonEntity: Name: NameFull: Pellegata NS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2025 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1423-0194 Numbering: – Type: volume Value: 115 – Type: issue Value: 5 Titles: – TitleFull: Neuroendocrinology Type: main |
| ResultId | 1 |